Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Systemic Lupus Erythematosus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05620407
What this trial is testing

Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Bristol-Myers Squibb 513
Testing effectiveness (Phase 2)Study completedNCT02804763
What this trial is testing

Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
UCB Biopharma S.P.R.L. 182
Early research (Phase 1)Not Yet RecruitingNCT06945068
What this trial is testing

An Open-label Study of GB261 in Refractory Seropositive Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 19
Large-scale testing (Phase 3)Study completedNCT03021499
What this trial is testing

Aurinia Renal Response in Active Lupus With Voclosporin

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 358
Testing effectiveness (Phase 2)Study completedNCT04186871
What this trial is testing

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

Who this might be right for
Autoimmune DisorderRheumatoid ArthritisSystemic Lupus Erythematosus+1 more
Bristol-Myers Squibb 119
Post-approval studies (Phase 4)Study completedNCT04908865
What this trial is testing

Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 67
Not applicableNot Yet RecruitingNCT06610409
What this trial is testing

Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity

Who this might be right for
SLE (Systemic Lupus)
Assiut University 90
Large-scale testing (Phase 3)Study completedNCT00377637
What this trial is testing

Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 370
Not applicableLooking for participantsNCT06718283
What this trial is testing

Assessment of Hematologic Indices in Juvenile Lupus Erythematosus Patients:Correlation With Disease Activity and Chronic Organ Damage in These Patients

Who this might be right for
Juvenile Systemic Lupus Erythematosus
Sohag University 50
Not applicableEnded earlyNCT01889654
What this trial is testing

Anti-nucleosome B Lymphocytes in Lupus

Who this might be right for
Systemic Lupus Erythematosus With or Without Clinical Activity
University Hospital, Strasbourg, France 4
Large-scale testing (Phase 3)Looking for participantsNCT05835310
What this trial is testing

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 100
Post-approval studies (Phase 4)Looking for participantsNCT07323524
What this trial is testing

Dapagliflozin in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Brigham and Women's Hospital 33
Not applicableLooking for participantsNCT07215754
What this trial is testing

Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: Investigator Initiated, Observational, Multicenter Study Evaluating Effectiveness and Safety of Anifrolumab in Active SLE Patients

Who this might be right for
Systemic Lupus Erythematosus
University of Pisa 300
Not applicableUnknownNCT03752983
What this trial is testing

Chemokine (CXCL13) as Anew Marker in Diagnosis of SLE

Who this might be right for
Systemic Lupus
Assiut University 86
Not applicableStudy completedNCT00401141
What this trial is testing

Abnormalities of B Lymphocytes During Systemic Lupus

Who this might be right for
Systemic Lupus Erythematosus
University Hospital, Strasbourg, France 30
Testing effectiveness (Phase 2)Looking for participantsNCT06058078
What this trial is testing

RY_SW01 Cell Injection Therapy in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Jiangsu Renocell Biotech Company 60
Testing effectiveness (Phase 2)Study completedNCT01085084
What this trial is testing

Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis

Who this might be right for
Lupus Arthritis
Teva Branded Pharmaceutical Products R&D, Inc. 82
Not applicableStudy completedNCT01923415
What this trial is testing

A Non-drug Study Profiling Cutaneous Lupus

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, SystemicLupus Erythematosus, Discoid
Janssen Research & Development, LLC 29
Not applicableStudy completedNCT03189875
What this trial is testing

Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 830
Testing effectiveness (Phase 2)Looking for participantsNCT06419205
What this trial is testing

Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Who this might be right for
IgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy
Akebia Therapeutics 30
Next Page